Who are Cannabis Sativa Oil's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): MediCabilis CBD Oil, Cannabis oil, Hemp, Cannabis Extract Oil SR Capsule, Placebo Matched to Low-Dose Cannabidiol, Moderate-Dose Cannabidiol.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/cannabis-sativa-oil.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-17 · How we verify

Cannabis Sativa Oil — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cannabis Sativa Oil (Cannabis Sativa Oil) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Phytocannabinoid preparation. Area: Pain management, Neurology, Immunology.

marketed Phytocannabinoid preparation CB1 receptor, CB2 receptor Pain management, Neurology, Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Cannabis Sativa Oil (Cannabis Sativa Oil) — Fondation pour l'accueil et l'hébérement des personnes âgées. Cannabis Sativa Oil contains phytocannabinoids (primarily THC and CBD) that interact with endocannabinoid receptors (CB1 and CB2) throughout the central and peripheral nervous systems.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Cannabis Sativa Oil TARGET	Cannabis Sativa Oil	Fondation pour l'accueil et l'hébérement des personnes âgées	marketed	Phytocannabinoid preparation	CB1 receptor, CB2 receptor
MediCabilis CBD Oil	MediCabilis CBD Oil	Gold Coast Hospital and Health Service	marketed	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor (multiple targets)
Cannabis oil	Cannabis oil	Assaf-Harofeh Medical Center	marketed	Phytocannabinoid preparation	CB1 receptor, CB2 receptor
Hemp	Hemp	Thammasat University Hospital	marketed	Phytocannabinoid preparation	CB1 receptor, CB2 receptor, TRPV1, 5-HT1A receptor
Cannabis Extract Oil SR Capsule	Cannabis Extract Oil SR Capsule	University of Sao Paulo General Hospital	marketed	Cannabinoid receptor modulator	CB1 receptor, CB2 receptor
Placebo Matched to Low-Dose Cannabidiol	Placebo Matched to Low-Dose Cannabidiol	Wayne State University	phase 3	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor
Moderate-Dose Cannabidiol	Moderate-Dose Cannabidiol	Wayne State University	phase 3	Cannabinoid	CB1 receptor, CB2 receptor, 5-HT1A receptor, TRPV1 receptor

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Phytocannabinoid preparation class)

Assaf-Harofeh Medical Center · 1 drug in this class
Fondation pour l'accueil et l'hébérement des personnes âgées · 1 drug in this class
Thammasat University Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cannabis Sativa Oil — Competitive Intelligence Brief. https://druglandscape.com/ci/cannabis-sativa-oil. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab